Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Targeted proteomics improves cardiovascular risk prediction in secondary prevention | Synapse

January 28, 2022Open Access

Ver artículo completo

Targeted proteomics improves cardiovascular risk prediction in secondary prevention

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

A proteome-based risk model is superior to a clinical risk model in predicting recurrent ASCVD events. Neutrophil-related pathways were found in low CRP patients, implying the presence of a residual inflammatory risk beyond traditional NLRP3 pathways. The observed net reclassification improvement illustrates the potential of proteomics when incorporated in a tailored therapeutic approach in secondary prevention patients.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Nurmohamed et al. (Fri,) studied this question.

synapsesocial.com/papers/69dd28e827c48be1bb40c3a5 https://doi.org/https://doi.org/10.1093/eurheartj/ehac055

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention2020 · 128 citations
2Permutation Tests for Studying Classifier Performance2009 · 580 citations
3Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease2017 · 6,022 citations
4Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction2015 · 414 citations
5Vasorin, a transforming growth factor β-binding protein expressed in vascular smooth muscle cells, modulates the arterial response to injury <i>in vivo</i>2004 · 141 citations